Oh, I understood from the 10 o'clock news last night that the Novovax (suddenly appeared out of the blue?) vaccine is not actually 'approved', but ready for the approval process, which takes several weeks. Or have I got this wrong?
But surely I'm right that the Oxford-Astrozenica vaccine was first tested predominantly on under 65s and had to undergo some extra tests for efficacy on over 65s which were necessarily less widely based and not tested over so long a period.
So I think that there has been a bit of sleight of hand with the figures, as with the Pfizer delay with the 2nd dose, in order to justify getting the first jab to as many as possible to as many as possible.